60760-993 (Metoprolol 60760 993 90)
This description is not-readable.*
Metoprolol Succinate Tablet, Extended Release
Product Images NDC 60760-993
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 60760-993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Picture-1 (Picture 1)
This is a description of results for subgroups in the MERIT-HF study, focusing on total mortality, total hospitalization for heart failure, and all-cause hospitalization for heart failure. The data includes characteristics such as NYHA classification, ejection fraction, etiology of heart failure, sex, race, history of myocardial infarction, diabetes mellitus, and heart rate. The information is presented in relation to extended-release metoprolol succinate tablets, with a breakdown by various factors such as NYHA class, ejection fraction, and ischemic etiology. Additional details on relative risk and 95% confidence intervals are also provided.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
